Portal de investigación
ENSAYO CLINICO, MULTICENTRICO, CONTROLADO, ALEATORIZADO, ENMASCARADO PARA COMPARAR LA SEGURIDAD Y LA EFECTIVIDAD DE SURFAXIN (LUCINANTANT) FRENTE A CUROSURF EN LA PREVENCION Y TRATAMIENTO DEL SINDROME DE DISTRES RESPIRATORIO (SDR) EN NEONATOS PREMATUROS.
Datos básicos
- Protocolo:
- KL4-IRDS-02
- EUDRACT:
- NO PROCEDE
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin
Moura, David S.; (...); Martin-Broto, Javier
Article. 10.1002/1878-0261.12996. 2021
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.
Martin-Broto, Javier; (...); Hindi, Nadia
Article. 10.1038/s41467-022-33975-6. 2022
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience.
Gutierrez, Antonio; (...); Geltamo
Article. 10.3390/cancers14112673. 2022
Autologous Stem Cell Transplantation Remains a Curative Option As Second Line Treatment for Patients with Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geth-TC/Geltamo Study
Bento, Leyre; (...); Garcia-Sancho, Alejandro Martin
Meeting Abstract. 10.1182/blood-2023-186730. 2023
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups
Bastos-Oreiro, Mariana; (...); Garcia-Sancho, Alejandro Martin
Article. 10.3389/fimmu.2022.855730. 2022
Clinical utility of Epitrack for differentiating profiles and patterns of post-surgical change in memory and quality of life in patients with drug-resistant epilepsy.
Lozano-García A; (...); González-Bono E
Article. 10.1080/23279095.2022.2036990. 2022
Characterizing SOD1 mutations in Spain. The impact of genotype, age, and sex in the natural history of the disease.
Vazquez-Costa, Juan F.; (...); Garcia-Redondo, Alberto
Article. 10.1111/ene.15661. 2022
Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry
Martinez-Marin, Rafael Jenaro; (...); Diaz-Manera, Jordi
Article. 10.1016/j.nmd.2023.10.001. 2024
El Método Canguro Durante La Pandemia Por Sars-Cov-2 En España.
Solaz-García Á; (...); Sáenz-González P
Case Reports. 10.1016/j.anpedi.2021.06.016. 2021
Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Ayyappan, Sabarish; (...); Prince, H. Miles
Meeting Abstract. 10.1182/blood-2023-179818. 2023
Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study
Iskierka-Jazdzewska, Elzbieta; (...); Ivanescu, Cristina
Meeting Abstract. 10.1182/blood-2023-180743. 2023
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
Moura, David S.; (...); Martin-Broto, Javier
Article. 10.1007/s00018-024-05250-y. 2024
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group
Rey-Bua, Beatriz; (...); Martin Garcia-Sancho, Alejandro
Article. 10.1158/1078-0432.CCR-24-0183. 2024
ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma
Martin Broto, Javier; (...); Hindi, Nadia
Meeting Abstract. 2023
Impact of Scholar-1 Refractoriness Criteria on the Efficacy of CAR-T Therapy in Aggressive B Cell Lymphoma, Compared with Non-Refractory Patients: A Real World Geltamo/Geth Study
Bastos-Oreiro, Mariana; (...); Martin Garcia-Sancho, Alejandro
Meeting Abstract. 10.1182/blood-2022-166329. 2022
Kangaroo care during the SARS-CoV-2 pandemic in Spain.
Solaz-García Á; (...); Sáenz-González P
Case Reports. 10.1016/j.anpede.2021.06.008. 2021
La reserva cognitiva como factor modulador del impacto de la cirugía sobre la memoria visual y la denominación en pacientes con epilepsia del lóbulo temporal.
Cano-Lopez, I; (...); Gonzalez-Bono, E
Article. 10.33588/rn.7308.2021109. 2021
Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2
Kim, Won-Seog; (...); Walewski, Jan
Meeting Abstract. 10.1182/blood-2022-158406. 2022
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A
Martin-Broto, Javier; (...); Hindi, Nadia
Article. 10.1038/s41392-023-01661-8. 2023
Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS).
Broto, Javier Martin; (...); Hindi, Nadia
Meeting Abstract. 2022
Phenotype and Distribution of Immature Neurons in the Human Cerebral Cortex Layer II
Coviello, Simona; (...); Nacher, Juan
Article. 10.3389/fnana.2022.851432. 2022
Preventive bundle approach decreases the incidence of ventilator-associated pneumonia in newborn infants.
Pinilla-González A; (...); Cernada M
Article. 10.1038/s41372-021-01086-7. 2021
Prognostic Factors and Treatment Strategy in Patients with Hodgkin Lymphoma and HIV Infection Treated with ABVD and CART: A Retrospective Study from Spanish Group Geltamo
Huguet, Maria; (...); Navarro, Jose-Tomas
Meeting Abstract. 10.1182/blood-2023-189756. 2023
Psychological burden and quality of life in newly diagnosed inflammatory bowel disease patients.
Bernabeu P; (...); Sempere L
Article. 10.3389/fpsyg.2024.1334308. 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study
Abrisqueta-Costa, Pau; (...); Loscertales, Javier
Article. 10.3390/cancers16234004. 2024
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study
Loscertales, Javier; (...); Garcia-Marco, Jose Antonio
Article. 10.3390/cancers15164047. 2023
Real-World Outcomes Using Front-Line Midostaurine in Combination with Intensive Chemotherapy for Patients Aged = 60 Years Old with FLT3 Mutated Acute Myeloid Leukemia
Requena, Gaspar Aspas; (...); Matinez-Cuadron, David
Meeting Abstract. 10.1182/blood-2023-190128. 2023